Efficacy and Tolerability of Erenumab in the Prophylactic Treatment of Persistent Post-Traumatic Headache

NCT03974360 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Post-Traumatic Headache
Mild Traumatic Brain Injury
Post-Concussion Syndrome

Interventions

DRUG: AMG 334

Sponsor

Danish Headache Center

Collaborators

[object Object]
[object Object]